Menu Search
Equities

ConvaTec Group PLC

CTEC:LSE

ConvaTec Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)239.00
  • Today's Change3.20 / 1.36%
  • Shares traded4.64m
  • 1 Year change+4.73%
  • Beta0.6671
Data delayed at least 20 minutes, as of Nov 25 2024 15:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform11
Hold2
Sell1
Strong Sell0

Share price forecast in USD

The 17 analysts offering 12 month price targets for ConvaTec Group PLC have a median target of 308.00, with a high estimate of 347.90 and a low estimate of 217.04. The median estimate represents a 30.62% increase from the last price of 235.80.
High47.5%347.90
Med30.6%308.00
Low-8.0%217.04

Dividends

In 2023, ConvaTec Group PLC reported a dividend of 0.07 USD, which represents a 9.77% increase over last year. The 19 analysts covering the company expect dividends of 0.07 USD for the upcoming fiscal year, a decrease of 3.40%.
Div growth (TTM)9.77%
More ▼

Earnings history & estimates in USD

ConvaTec Group PLC reported annual 2023 earnings of 0.134 per share on Mar 06, 2024.
Average growth rate+2.85%
More ▼

Revenue history & estimates in USD

Convatec Group Plc had revenues for the full year 2023 of 2.14bn. This was 3.37% above the prior year's results.
Average growth rate+4.08%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.